Answers are grounded in this paper and cite their sources.
Dear Editor, here we report the behavioral and neurophysiological effects of individualized rTMS administration to language networks in a patient with logopenic variant primary progressive aphasia (lvPPA). The core features of lvPPA include impaired single-word retrieval in spontaneous speech, and impaired repetition (Gorno-TeSmpini et al., 2011). There are currently no treatments definitively shown to slow, stop or reverse the progression of the primary speech and language symptoms in lvPPA.
No takes yet. Share an insight, caveat, or question.
Touroutoglou et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: